Drug
Bn104 Monotherapy
Bn104 Monotherapy: highest development phase Phase 1/2, developed by Servier. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1/2
- Developer
- Servier
Trials
| Drug | Phase | Indication |
|---|---|---|
| BN104 monotherapy NCT06052813 | Phase 1/2 | ALL, Adult |
Latest
No recent events.
Follow Bn104 Monotherapy on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.